Jacqueline Gollan
Affiliations: | Clinical Psychology | Northwestern University, Evanston, IL |
Area:
Clinical Psychology, Cognitive Psychology, Behavioral PsychologyGoogle:
"Jacqueline Gollan"Mean distance: 53433
Children
Sign in to add traineeKelly Blum | grad student | Northwestern School of Medicine | |
Angel Buchanan | grad student | Northwestern School of Medicine | |
Megan Connolly | grad student | Northwestern School of Medicine | |
Rachel H. Jacobs | grad student | Northwestern (PsychTree) | |
Jennifer Medina | grad student | Northwestern School of Medicine | |
Jason Osher | grad student | Northwestern School of Medicine | |
Laina Rosebrock | grad student | Northwestern School of Medicine | |
Lindsey Sankin | grad student | Northwestern School of Medicine | |
Maureen Satyshur | grad student | Northwestern School of Medicine | |
Kallio Hunnicutt-Ferguson | grad student | 2014 | Northwestern |
Denada Hoxha | post-doc | Northwestern School of Medicine (EduTree) | |
Daniel Mortensen | post-doc | Northwestern School of Medicine (Chemistry Tree) | |
Jonathan Sutton | post-doc | Northwestern School of Medicine |
Collaborators
Sign in to add collaboratorJohn T. Cacioppo | collaborator | Chicago | |
Brian Hitsman | collaborator | Northwestern School of Medicine | |
Emily Miller Stinnett | collaborator | Northwestern School of Medicine | |
Darius Tandon | collaborator | Northwestern School of Medicine | |
Katherine Wisner | collaborator | Northwestern School of Medicine |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Salisbury AL, Anderson GM, Yang A, et al. (2024) Fetal behavior and gestational serotonin reuptake inhibitor exposure: relationships between behavior, drug dosage, plasma drug level, and a measure of drug bioeffect. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
Mayer JLW, Betcher HK, Rasmussen-Torvik LJ, et al. (2024) Pharmacogenomic Characterization of Childbearing-Aged Individuals With Mood Disorders in a Tertiary Care Perinatal Mental Health Clinic. The Journal of Clinical Psychiatry. 85 |
Hitsman B, Papandonatos GD, Fox EN, et al. (2024) Effect of early medication adherence on behavioral treatment utilization and smoking cessation among individuals with current or past major depressive disorder. Addictive Behaviors. 151: 107952 |
Mayer JLW, Yang A, Wisner KL, et al. (2023) Factors Associated with Depressive and Anxiety Symptom Trajectories Across Pregnancy and Postpartum in Selective Serotonin Reuptake Inhibitor-Treated Individuals. Psychiatric Research and Clinical Practice. 5: 144-147 |
Gollan JK, Liverant G, Jao NC, et al. (2023) Depression Severity Moderates Reward Learning Among Smokers with Current or Past Major Depressive Disorder in a Smoking Cessation Randomized Clinical Trial. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco |
Schnoll R, Wileyto EP, Bauer AM, et al. (2023) Seeing Through the Blind: Belief about Treatment Randomization and Smoking Cessation Outcome among People with Current or Past Major Depressive Disorder who Smoke in a Placebo-Controlled Trial of Varenicline. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco |
Hitsman B, Papandonatos GD, Gollan JK, et al. (2023) Efficacy and Safety of Combination Behavioral Activation for Smoking Cessation and Varenicline for Treating Tobacco Dependence among Individuals with Current or Past Major Depressive Disorder: A 2x2 Factorial, Randomized, Placebo-Controlled Trial. Addiction (Abingdon, England) |
Schnoll R, Barrila GM, Dalsimer S, et al. (2023) Treatment adherence in a smoking cessation clinical trial for individuals with current or past major depressive disorder: Predictors and association with cessation. Addictive Behaviors. 143: 107686 |
Burnett-Zeigler I, Zhou E, Martinez JH, et al. (2023) Comparative effectiveness of a mindfulness-based intervention (M-Body) on depressive symptoms: study protocol of a randomized controlled trial in a Federally Qualified Health Center (FQHC). Trials. 24: 115 |
Mesches GA, Ciolino JD, Stika CS, et al. (2022) Trajectories of Depressive and Anxiety Symptoms Across Pregnancy and Postpartum in Selective Serotonin Reuptake Inhibitor-Treated Women. Psychiatric Research and Clinical Practice. 4: 32-41 |